​

Oruka Therapeutics Ownership | Who Owns Oruka Therapeutics?

OverviewForecastChart

Oruka Therapeutics Ownership Summary

Oruka Therapeutics is owned by 135.06% institutional investors, 1.12% insiders. Fmr is the largest institutional shareholder, holding 16.42% of ORKA shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.86% of its assets in Oruka Therapeutics shares.

ORKA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOruka Therapeutics135.06%1.12%-36.18%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryBiotech Stocks 49.09%12.06%38.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr9.06M16.42%$862.02M
Blackrock funding, inc. /de4.99M9.04%$474.92M
Vr adviser4.15M7.52%$394.81M
Fairmount funds management3.71M6.72%$352.63M
Capital world investors3.40M6.17%$323.73M
Rtw investments, lp3.14M5.69%$298.74M
Vanguard group2.45M5.57%$74.37M
State street2.67M4.84%$254.38M
Vanguard capital management2.36M4.28%$224.69M
Paradigm biocapital advisors lp2.14M3.89%$204.09M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fairmount funds management3.71M23.31%$352.63M
Vr adviser4.15M11.97%$394.81M
Avidity partners management lp760.42K11.59%$72.37M
Paradigm biocapital advisors lp2.14M3.82%$204.09M
Silverarc capital management352.80K3.49%$33.58M
B group75.00K3.35%$7.14M
Bellevue group1.66M3.32%$157.71M
Great point partners183.33K3.30%$17.45M
Synergy asset management356.30K3.20%$33.91M
Sio capital management177.12K2.79%$16.86M

Top Buyers

HolderShares% AssetsChange
Capital world investors3.40M0.04%3.40M
Fmr9.06M0.04%1.63M
Ra capital management1.55M1.29%1.55M
Blackrock funding, inc. /de4.99M0.01%1.46M
Bellevue group1.66M3.32%1.15M

Top Sellers

HolderShares% AssetsChange
Commodore capital lp---1.75M
Avoro capital advisors---1.33M
Viking global investors lp1.50M0.41%-1.16M
Mercer global advisors inc /adv1.08K0.00%-801.39K
Point72 asset management---600.00K

New Positions

HolderShares% AssetsChangeValue
Capital world investors3.40M0.04%3.40M$323.73M
Ra capital management1.55M1.29%1.55M$147.95M
T. rowe price investment management1.10M0.07%1.10M$105.04M
Summit partners public asset management658.30K1.10%658.30K$62.65M
Pictet asset management sa619.08K0.06%619.08K$58.91M

Sold Out

HolderChange
Mai capital management-1.00
Golden state equity partners-8.00
Ameritas advisory services-11.00
True wealth design-26.00
Rise advisors-36.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202626340.64%74,518,41643.25%1351.52%19554.76%4746.88%
Mar 31, 202618226.39%52,177,550-1.28%1140.80%12525.00%3087.50%
Dec 31, 202562-43.12%11,958,114-73.75%270.23%45-28.57%4-82.61%
Sep 30, 202542-48.15%6,253,192-81.84%140.22%25-51.92%9-35.71%
Jun 30, 20258017.65%34,421,52522.70%811.80%5320.45%1427.27%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Morn Total Stk Mkt Idx Investor1.73M2.86%5.92K
Vanguard Total Stock Mkt Idx Inv1.73M2.86%5.92K
Fidelity Growth Compy Commingled Pl S1.70M2.81%54.10K
American Funds SMALLCAP World A1.53M2.53%1.53M
State Street® SPDR® S&P® Biotech ETF1.53M2.53%3.50K
Capital Group New Economy Comp1.32M2.19%1.32M
American Funds New Economy A1.32M2.19%1.32M
iShares Russell 2000 ETF1.28M2.13%-22.75K
Fidelity Growth Company Fund1.26M2.09%39.44K
Polar Capital Biotech S Inc1.16M1.93%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 17, 2026Goncalves Joana Chief Medical OfficerSell$371.89K
Aug 17, 2026Goncalves Joana Chief Medical OfficerSell$279.15K
Aug 17, 2026Goncalves Joana Chief Medical OfficerSell$98.69K
Aug 17, 2026Goncalves Joana Chief Medical OfficerSell$33.16K
Aug 14, 2026Quinlan Paul T General CounselSell$1.11M

Insider Transactions Trends

DateBuySell
2026 Q3-27
2026 Q2-34
2026 Q1-17
2025 Q4-4
2025 Q3--

ORKA Ownership FAQ

Who Owns Oruka Therapeutics?

Oruka Therapeutics shareholders are primarily institutional investors at 135.06%, followed by 1.12% insiders and -36.18% retail investors. The average institutional ownership in Oruka Therapeutics's industry, Biotech Stocks , is 49.09%, which Oruka Therapeutics exceeds.

Who owns the most shares of Oruka Therapeutics?

Oruka Therapeutics’s largest shareholders are Fmr (9.06M shares, 16.42%), Blackrock funding, inc. /de (4.99M shares, 9.04%), and Vr adviser (4.15M shares, 7.52%). Together, they hold 32.98% of Oruka Therapeutics’s total shares outstanding.

Does Blackrock own Oruka Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Oruka Therapeutics.

Who is Oruka Therapeutics’s biggest shareholder by percentage of total assets invested?

Fairmount funds management is Oruka Therapeutics’s biggest shareholder by percentage of total assets invested, with 23.31% of its assets in 3.71M Oruka Therapeutics shares, valued at 352.63M$.

Who is the top mutual fund holder of Oruka Therapeutics shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Oruka Therapeutics shares, with 2.86% of its total shares outstanding invested in 1.73M Oruka Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools